Compares outcomes of hybrid coronary revascularization and off-pump coronary artery bypass surgery, indicating viability for treatment.
HCR demonstrated comparable short-term and midterm outcomes to OPCAB, suggesting it is a viable alternative for multivessel coronary artery disease treatment. However, further research is necessary to assess long-term effectiveness and to identify specific patient populations who may benefit most from HCR.
No takes yet. Share an insight, caveat, or question.
Gianoli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: